Medexus Pharmaceuticals Inc. (MEDXF)

Medexus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	6.97	5.26	13.07	10.02	18.7	5.23
Cash & Short-Term Investments	6.97	5.26	13.07	10.02	18.7	5.23
Cash Growth	-64.24%	-59.79%	30.46%	-46.44%	257.42%	-82.08%
Accounts Receivable	13.05	23.87	21.97	13.39	18.4	14.74
Other Receivables	-	0.16	0.41	1.02	0.43	0.22
Receivables	13.05	24.03	22.38	14.41	18.83	14.96
Inventory	38.17	30.77	22.85	21.35	14.67	14.08
Prepaid Expenses	5.62	10.14	12.38	2.06	4.71	4.35
Other Current Assets	0.39	2.3	2.3	1.28	1.67	1.11
Total Current Assets	64.2	72.5	72.97	49.11	58.57	39.73
Property, Plant & Equipment	0.73	0.78	0.9	1.22	0.8	1.1
Goodwill	10.3	10.28	10.28	10.69	10.65	10.06
Other Intangible Assets	61.33	64.14	70.37	76.57	76.36	69.77
Long-Term Deferred Tax Assets	8.82	8.04	6.81	-	-	-
Other Long-Term Assets	-	-	-	1.64	2.13	2.12
Total Assets	145.37	155.73	161.33	139.23	148.51	122.77
Accounts Payable	37.12	7.75	10.16	12.05	14.86	8.9
Accrued Expenses	-	35.48	23.26	17.13	12.47	13.28
Current Portion of Long-Term Debt	17.76	15.56	42.71	15.05	10.57	10.19
Current Portion of Leases	-	0.19	-	-	-	-
Current Income Taxes Payable	1.26	1.32	1.18	0.03	0.51	0.68
Other Current Liabilities	7.32	5.94	6.19	3.86	1.53	1.1
Total Current Liabilities	63.45	66.23	83.5	48.11	39.94	34.16
Long-Term Debt	24.74	33.8	26.78	39.03	34.09	28.05
Long-Term Leases	0.48	0.35	0.6	0.78	0.21	0.56
Long-Term Deferred Tax Liabilities	-	-	-	1.52	2.65	6.48
Other Long-Term Liabilities	23.96	25.03	28.01	31.99	53.61	29.25
Total Liabilities	112.63	125.41	138.88	121.43	130.5	98.5
Common Stock	76.72	76.39	69.01	68.69	66.69	44.76
Additional Paid-In Capital	11.96	12.01	11.31	10.38	9.5	7.04
Retained Earnings	-62.18	-64.24	-64.03	-65.25	-62.37	-34.11
Comprehensive Income & Other	6.23	6.17	6.16	3.97	4.2	6.58
Shareholders' Equity	32.74	30.32	22.45	17.79	18.02	24.28
Total Liabilities & Equity	145.37	155.73	161.33	139.23	148.51	122.77
Total Debt	42.97	49.9	70.08	54.86	44.87	38.8
Net Cash (Debt)	-36	-44.64	-57.01	-44.84	-26.17	-33.56
Net Cash Per Share	-1.47	-1.99	-2.78	-2.26	-1.72	-2.34
Filing Date Shares Outstanding	24.65	24.46	20.25	19.95	19.17	14.45
Total Common Shares Outstanding	24.65	24.46	20.18	19.95	19.17	14.45
Working Capital	0.75	6.27	-10.53	1	18.63	5.57
Book Value Per Share	1.33	1.24	1.11	0.89	0.94	1.68
Tangible Book Value	-38.88	-44.09	-58.21	-69.46	-69	-55.55
Tangible Book Value Per Share	-1.58	-1.80	-2.88	-3.48	-3.60	-3.84
Machinery	1.19	1.12	1.07	1.06	0.96	0.85

Source: S&P Capital IQ. Standard template. Financial Sources.